Ajanta Pharma Limited (BOM:532331)
India flag India · Delayed Price · Currency is INR
3,383.95
+17.50 (0.52%)
At close: Jul 27, 2026

Ajanta Pharma Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
10,5609,2048,1625,8807,127
Depreciation & Amortization
1,7311,3591,3041,2671,214
Other Amortization
-82.250.14139.4
Loss (Gain) From Sale of Assets
18.76-34.961.938.7
Loss (Gain) From Sale of Investments
-80.4-113.1-20.114.8-52.3
Stock-Based Compensation
15.338.854.92.23
Other Operating Activities
-423.8-793.7-667.1-14.1-748.2
Change in Accounts Receivable
-5,908804.8-1,789-105.5-2,697
Change in Inventory
-309.5-745.1-123-223.7-256.6
Change in Accounts Payable
907.9-84.5408.5969.1-480.2
Change in Other Net Operating Assets
-1,2191,814505.528.61,430
Operating Cash Flow
5,29211,5727,8517,9215,617
Operating Cash Flow Growth
-54.27%47.41%-0.89%41.02%-2.53%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-3,652-3,179-1,524-1,745-1,488
Sale of Property, Plant & Equipment
54.111.4133.87.3183.8
Investment in Securities
-1,142-1,0401,776-3,907287.8
Other Investing Activities
449.8442.4267.948.7275.8
Investing Cash Flow
-4,289-3,765653.9-5,596-741

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
2,094110.6-2.3
Total Debt Issued
2,094110.6-2.3
Long-Term Debt Repaid
-114.9-114.6-125.5-112.3-137.5
Net Debt Issued (Repaid)
1,979-103.6-124.9-112.3-135.2
Issuance of Common Stock
-0.1---
Repurchase of Common Stock
--3,513-3,883--2,856
Common Dividends Paid
-3,497-3,494-6,422-896.9-822.1
Other Financing Activities
-161.1-223.5-81.3-72.8-783.9
Financing Cash Flow
-1,679-7,334-10,511-1,082-4,597

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Cash Flow
-676.5473-2,0061,243279

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
1,6408,3936,3276,1764,129
Free Cash Flow Growth
-80.46%32.66%2.44%49.59%2.02%
Free Cash Flow Margin
3.01%18.06%15.03%16.50%12.36%
Free Cash Flow Per Share
13.1367.0550.2148.2031.84
Levered Free Cash Flow
8.686,6211,1658,1461,893
Unlevered Free Cash Flow
109.366,7501,2108,1831,956

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
161.1207.472.158.4102
Cash Income Tax Paid
3,5903,2303,1211,5132,391
Change in Working Capital
-6,5291,789-997.8668.5-2,004